• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Rac1 GTP酶调节2型11β-羟类固醇脱氢酶和纤维化重塑。

Rac1 GTPase regulates 11β hydroxysteroid dehydrogenase type 2 and fibrotic remodeling.

作者信息

Lavall Daniel, Schuster Pia, Jacobs Nadine, Kazakov Andrey, Böhm Michael, Laufs Ulrich

机构信息

From the Universität des Saarlandes, Klinik für Innere Medizin III-Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, D-66421 Homburg/Saar, Germany

From the Universität des Saarlandes, Klinik für Innere Medizin III-Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, D-66421 Homburg/Saar, Germany.

出版信息

J Biol Chem. 2017 May 5;292(18):7542-7553. doi: 10.1074/jbc.M116.764449. Epub 2017 Mar 20.

DOI:10.1074/jbc.M116.764449
PMID:28320863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5418052/
Abstract

The aim of the study was to characterize the role of Rac1 GTPase for the mineralocorticoid receptor (MR)-mediated pro-fibrotic remodeling. Transgenic mice with cardiac overexpression of constitutively active Rac1 (RacET) develop an age-dependent phenotype with atrial dilatation, fibrosis, and atrial fibrillation. Expression of MR was similar in RacET and WT mice. The expression of 11β hydroxysteroid dehydrogenase type 2 (11β-HSD2) was age-dependently up-regulated in the atria and the left ventricles of RacET mice on mRNA and protein levels. Statin treatment inhibiting Rac1 geranylgeranylation reduced 11β-HSD2 up-regulation. Samples of human left atrial myocardium showed a positive correlation between Rac1 activity and 11β-HSD2 expression ( = 0.7169). Immunoprecipitation showed enhanced Rac1-bound 11β-HSD2 relative to Rac1 expression in RacET mice that was diminished with statin treatment. Both basal and phorbol 12-myristate 13-acetate (PMA)-induced NADPH oxidase activity were increased in RacET and correlated positively with 11β-HSD2 expression ( = 0.788 and = 0.843, respectively). In cultured H9c2 cardiomyocytes, Rac1 activation with l-buthionine sulfoximine increased; Rac1 inhibition with NSC23766 decreased 11β-HSD2 mRNA and protein expression. Connective tissue growth factor (CTGF) up-regulation induced by aldosterone was prevented with NSC23766. Cardiomyocyte transfection with 11β-HSD2 siRNA abolished the aldosterone-induced CTGF up-regulation. Aldosterone-stimulated MR nuclear translocation was blocked by the 11β-HSD2 inhibitor carbenoxolone. In cardiac fibroblasts, nuclear MR translocation induced by aldosterone was inhibited with NSC23766 and spironolactone. NSC23766 prevented the aldosterone-induced proliferation and migration of cardiac fibroblasts and the up-regulation of CTGF and fibronectin. In conclusion, Rac1 GTPase regulates 11β-HSD2 expression, MR activation, and MR-mediated pro-fibrotic signaling.

摘要

本研究的目的是阐明Rac1 GTP酶在盐皮质激素受体(MR)介导的促纤维化重塑中的作用。心脏中组成型活性Rac1过表达的转基因小鼠(RacET)会出现与年龄相关的表型,包括心房扩张、纤维化和心房颤动。RacET小鼠和野生型(WT)小鼠中MR的表达相似。在RacET小鼠的心房和左心室中,2型11β羟类固醇脱氢酶(11β-HSD2)的表达在mRNA和蛋白质水平上均呈年龄依赖性上调。抑制Rac1香叶基香叶基化的他汀类药物治疗可降低11β-HSD2的上调。人类左心房心肌样本显示Rac1活性与11β-HSD2表达之间呈正相关(r = 0.7169)。免疫沉淀显示,相对于Rac1表达,RacET小鼠中与Rac1结合的11β-HSD2增强,而他汀类药物治疗可使其减少。RacET小鼠的基础和佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)诱导的NADPH氧化酶活性均增加,且与11β-HSD2表达呈正相关(分别为r = 0.788和r = 0.843)。在培养的H9c2心肌细胞中,用L-丁硫氨酸亚砜胺激活Rac1会增加;用NSC23766抑制Rac1会降低11β-HSD2的mRNA和蛋白质表达。NSC23766可阻止醛固酮诱导的结缔组织生长因子(CTGF)上调。用11β-HSD2小干扰RNA转染心肌细胞可消除醛固酮诱导的CTGF上调。醛固酮刺激的MR核转位被11β-HSD2抑制剂甘草次酸阻断。在心脏成纤维细胞中,NSC23766和螺内酯可抑制醛固酮诱导的MR核转位。NSC23766可阻止醛固酮诱导的心脏成纤维细胞增殖和迁移以及CTGF和纤连蛋白的上调。总之,Rac1 GTP酶调节11β-HSD2表达、MR激活以及MR介导的促纤维化信号传导。

相似文献

1
Rac1 GTPase regulates 11β hydroxysteroid dehydrogenase type 2 and fibrotic remodeling.Rac1 GTP酶调节2型11β-羟类固醇脱氢酶和纤维化重塑。
J Biol Chem. 2017 May 5;292(18):7542-7553. doi: 10.1074/jbc.M116.764449. Epub 2017 Mar 20.
2
The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.醛固酮受体促进心房颤动中的纤维重塑。
J Biol Chem. 2014 Mar 7;289(10):6656-6668. doi: 10.1074/jbc.M113.519256. Epub 2014 Jan 27.
3
The non-steroidal mineralocorticoid receptor antagonist finerenone prevents cardiac fibrotic remodeling.非甾体类盐皮质激素受体拮抗剂非奈利酮可预防心脏纤维化重塑。
Biochem Pharmacol. 2019 Oct;168:173-183. doi: 10.1016/j.bcp.2019.07.001. Epub 2019 Jul 5.
4
Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation.Rac1 诱导的结缔组织生长因子调节心房颤动中的连接蛋白 43 和 N-钙黏蛋白表达。
J Am Coll Cardiol. 2010 Feb 2;55(5):469-80. doi: 10.1016/j.jacc.2009.08.064.
5
Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation.心房颤动时赖氨酰氧化酶表达增加和胶原交联。
J Mol Cell Cardiol. 2011 Apr;50(4):678-85. doi: 10.1016/j.yjmcc.2010.12.019. Epub 2011 Jan 6.
6
Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.螺内酯调节心肌盐皮质激素受体和11β-羟基类固醇脱氢酶2的表达,并预防心肌梗死后大鼠心脏的心室重构。
Hypertens Res. 2007 May;30(5):427-37. doi: 10.1291/hypres.30.427.
7
Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice.托拉塞米对醛固酮合成酶(CYP11B2)的抑制作用可预防小鼠心房纤维化和心房颤动。
J Mol Cell Cardiol. 2015 Aug;85:140-50. doi: 10.1016/j.yjmcc.2015.05.019. Epub 2015 Jun 3.
8
Tumor necrosis factor alpha and phorbol 12-myristate-13-acetate down-regulate human 11beta-hydroxysteroid dehydrogenase type 2 through p50/p50 NF-kappaB homodimers and Egr-1.肿瘤坏死因子α和佛波醇12-肉豆蔻酸酯-13-乙酸酯通过p50/p50核因子κB同型二聚体和早期生长反应蛋白1下调人2型11β-羟基类固醇脱氢酶。
FASEB J. 2005 Apr;19(6):650-2. doi: 10.1096/fj.04-2820fje. Epub 2005 Jan 19.
9
The intracellular localization of the mineralocorticoid receptor is regulated by 11beta-hydroxysteroid dehydrogenase type 2.盐皮质激素受体的细胞内定位受2型11β-羟基类固醇脱氢酶调控。
J Biol Chem. 2001 Jul 27;276(30):28484-92. doi: 10.1074/jbc.M100374200. Epub 2001 May 11.
10
Direct fibrogenic effects of aldosterone on normotensive kidney: an effect modified by 11β-HSD activity.醛固酮对正常血压肾脏的直接成纤维作用:11β-HSD 活性对其的影响。
Am J Physiol Renal Physiol. 2010 May;298(5):F1178-87. doi: 10.1152/ajprenal.00532.2009. Epub 2010 Mar 3.

引用本文的文献

1
NADPH Oxidases and Oxidative Stress in the Pathogenesis of Atrial Fibrillation.NADPH氧化酶与氧化应激在心房颤动发病机制中的作用
Antioxidants (Basel). 2023 Oct 6;12(10):1833. doi: 10.3390/antiox12101833.
2
Mineralocorticoid Receptor Antagonists for Preventing Chronic Kidney Disease Progression: Current Evidence and Future Challenges.醛固酮受体拮抗剂预防慢性肾脏病进展:当前的证据和未来的挑战。
Int J Mol Sci. 2023 Apr 23;24(9):7719. doi: 10.3390/ijms24097719.
3
Rac1 inhibition protects the kidney against kidney ischemia/reperfusion through the inhibition of macrophage migration.Rac1抑制通过抑制巨噬细胞迁移来保护肾脏免受肾缺血/再灌注损伤。
Korean J Physiol Pharmacol. 2023 May 1;27(3):257-265. doi: 10.4196/kjpp.2023.27.3.257.
4
Pharmacological Inhibition of P-Rex1/Rac1 Axis Blocked Angiotensin II-Induced Cardiac Fibrosis.药理学抑制 P-Rex1/Rac1 轴可阻断血管紧张素 II 诱导的心肌纤维化。
Cardiovasc Drugs Ther. 2024 Oct;38(5):861-872. doi: 10.1007/s10557-023-07442-3. Epub 2023 Mar 9.
5
Cardiac Hypertrophy and Related Dysfunctions in Cushing Syndrome Patients-Literature Review.库欣综合征患者的心脏肥大及相关功能障碍——文献综述
J Clin Med. 2022 Nov 28;11(23):7035. doi: 10.3390/jcm11237035.
6
Network meta-analysis on the efficacy and safety of finerenone versus SGLT2 inhibitors on reducing new-onset of atrial fibrillation in patients with type 2 diabetes mellitus and chronic kidney disease.非奈利酮与钠-葡萄糖协同转运蛋白2抑制剂对2型糖尿病合并慢性肾脏病患者降低新发房颤疗效和安全性的网络荟萃分析
Diabetol Metab Syndr. 2022 Oct 27;14(1):156. doi: 10.1186/s13098-022-00929-3.
7
Dock10 Regulates Cardiac Function under Neurohormonal Stress.Dock10 调节神经激素应激下的心脏功能。
Int J Mol Sci. 2022 Aug 25;23(17):9616. doi: 10.3390/ijms23179616.
8
Inhibition of GTPase Rac1 expression by vitamin D mitigates pressure overload-induced cardiac hypertrophy.维生素D对GTP酶Rac1表达的抑制作用可减轻压力超负荷诱导的心肌肥大。
Int J Cardiol Heart Vasc. 2021 Nov 30;37:100922. doi: 10.1016/j.ijcha.2021.100922. eCollection 2021 Dec.
9
Aldosterone from endometrial glands is benefit for human decidualization.子宫内膜腺的醛固酮有利于人类蜕膜化。
Cell Death Dis. 2020 Aug 13;11(8):679. doi: 10.1038/s41419-020-02844-9.
10
Increased flux through the mevalonate pathway mediates fibrotic repair without injury.甲羟戊酸途径通量增加介导无损伤性纤维化修复。
J Clin Invest. 2019 Nov 1;129(11):4962-4978. doi: 10.1172/JCI127959.

本文引用的文献

1
Metformin inhibits aldosterone-induced cardiac fibroblast activation, migration and proliferation in vitro, and reverses aldosterone+salt-induced cardiac fibrosis in vivo.二甲双胍在体外可抑制醛固酮诱导的心脏成纤维细胞激活、迁移和增殖,并在体内逆转醛固酮加食盐诱导的心脏纤维化。
J Mol Cell Cardiol. 2016 Sep;98:95-102. doi: 10.1016/j.yjmcc.2016.07.006. Epub 2016 Jul 14.
2
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南:欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗工作组编写,欧洲心脏病学会心力衰竭协会(HFA)提供特别贡献。
Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.
3
Perioperative Rosuvastatin in Cardiac Surgery.心脏手术中的围手术期瑞舒伐他汀。
N Engl J Med. 2016 May 5;374(18):1744-53. doi: 10.1056/NEJMoa1507750.
4
Cardiac Fibrosis: The Fibroblast Awakens.心脏纤维化:成纤维细胞觉醒
Circ Res. 2016 Mar 18;118(6):1021-40. doi: 10.1161/CIRCRESAHA.115.306565.
5
Rac1-Mediated Activation of Mineralocorticoid Receptor in Pressure Overload-Induced Cardiac Injury.Rac1介导的盐皮质激素受体激活在压力超负荷诱导的心脏损伤中的作用
Hypertension. 2016 Jan;67(1):99-106. doi: 10.1161/HYPERTENSIONAHA.115.06054. Epub 2015 Nov 2.
6
Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications.心房颤动患者的心肌纤维化:机制与临床意义。
J Am Coll Cardiol. 2015 Aug 25;66(8):943-59. doi: 10.1016/j.jacc.2015.06.1313.
7
Fibrosis--a common pathway to organ injury and failure.纤维化——器官损伤和衰竭的常见途径。
N Engl J Med. 2015 Mar 19;372(12):1138-49. doi: 10.1056/NEJMra1300575.
8
Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases.盐皮质激素受体激活与盐皮质激素受体拮抗剂在心脏和肾脏疾病中的治疗作用
Hypertension. 2015 Feb;65(2):257-63. doi: 10.1161/HYPERTENSIONAHA.114.04488. Epub 2014 Nov 3.
9
The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.醛固酮受体促进心房颤动中的纤维重塑。
J Biol Chem. 2014 Mar 7;289(10):6656-6668. doi: 10.1074/jbc.M113.519256. Epub 2014 Jan 27.
10
Mineralocorticoid receptor--Rac1 activation and oxidative stress play major roles in salt-induced hypertension and kidney injury in prepubertal rats.盐诱导的青春期前大鼠高血压和肾损伤中,醛固酮受体-Rac1 激活和氧化应激起主要作用。
J Hypertens. 2012 Oct;30(10):1977-85. doi: 10.1097/HJH.0b013e3283576904.